期刊文献+

行血液透析和肾移植的青壮年终末期肾脏病患者生存质量比较及其影响因素探讨 被引量:4

下载PDF
导出
摘要 目的比较血液透析(HD)和肾移植(KT)对青壮年终末期肾脏病(ESRD)患者生存质量的影响,并探讨生存质量的影响因素。方法回顾性研究HD和KT应用于青壮年ESRD患者治疗2~3年后并发症发生和健康指导情况、对工作的影响以及现阶段的生活质量(用SF-36量表评价),并进行相关分析。结果与行HD的青壮年ESRD患者比较,行KT的ESRD患者血压、血磷低,心脏并发症、脑血管疾病发生率低,血红蛋白水平高,健康指导情况优、回返工作比例高,SF-36相关8个分支领域评分高(P均〈0.05)。结论行KT的青壮年ESRD患者总体生存质量优于行HD者;健康指导与医疗保健是影响生存质量的关键因素。
作者 左富姐 韩澍
出处 《山东医药》 CAS 2014年第41期51-52,58,共3页 Shandong Medical Journal
  • 相关文献

参考文献10

  • 1Panagopoulou A, Hardalias A, Berati S, et al. Psychosocial issues and quality of life in patients on renal replacement therapy [ J ]. Sa- udi J Kidney Dis Transpl, 2009,20(2) :212-218.
  • 2Zhang All, Cheng LT, Zhu N, et al. Comparison of quality of life and cases of hospitalization between hemodialysis and peritoneal dialysis patients in China[J]. Health Qual Life Outcomes, 2007,5:49.
  • 3彭贵军,吴耀松,陈玉龙,张翥,王光策.尿毒症患者116例肾移植后生活质量的调查[J].中国组织工程研究与临床康复,2011,15(5):909-912. 被引量:4
  • 4Jenkinson C, Wright L, Coulter A. Criterion validity and reliability of the SF-36 in a population sample[J]. Qual Life Res, 1994,3 ( 1 ) :7-12.
  • 5Campolina AG, Ciconelli RM. SF-36 and the development of new assessment tools for quality of life[ J]. Acta Reumatol Port, 2008, 33(2) :127-133.
  • 6McPake D, Burnapp L. Caring for patients 'after kidney transplan- tation[ J ]. Nurs Stand, 2009,23 ( 19 ) :49-57.
  • 7Ferradini MA, Pogliani D. Quality of life after kidney transplant [J]. G hal Nefrol, 2008,25(5) :581-585.
  • 8马勤,冯莺,黄月星,雷小华.透析前教育对慢性肾衰竭患者生活质量的影响[J].中国中西医结合肾病杂志,2009,10(9):805-807. 被引量:7
  • 9狄桂萍,李萍萍,廖秀梅,李志辉,郑清友.亲属活体肾移植供者术后长期生活质量随访调查(附41例报告)[J].临床误诊误治,2012,25(9):57-60. 被引量:6
  • 10文吉秋,纪玉莲,郑智华,马祖等,彭炎强,余学清.血液透析、腹膜透析和肾移植的成本-效果分析[J].中华肾脏病杂志,2005,21(10):66-69. 被引量:19

二级参考文献45

  • 1马祖等,郑智华,张涤华,郝元涛,叶任高,娄探奇,毛晓玲,刘岩,刘冠贤,朱起之,张增华,汪华林,傅君舟,余学清.血液透析和腹膜透析患者生存质量的多中心调查[J].中华肾脏病杂志,2004,20(6):400-405. 被引量:87
  • 2Roy DJ. Dignity dialysis and dying. Dial Transplant, 1990, 19 (1):19-21.
  • 3NKF - K/DOQI. Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000. Am J Kidney Dis, 2001,37, (Suppl 1 ) :S65 - S136.
  • 4Wu AW, Fink NE, Marsh - Manzi JV. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. Journal of the American Society of Nephrology, 2004,15(3) :743 - 753.
  • 5Plantinga LC, Fink NE, Jaar BG, et al. Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res. 2007;16(5): 755-765.
  • 6Franke GH, Trampenau C, Reimer J, et al. Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation. Transplant Proc. 2006;38(5): 1293-1294.
  • 7WaSSe H, Kutner N, Zhang R, et al. Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc NeDhrol. 2007;2(4): 708-714.
  • 8Kalender B, Ozdemir AC, Dervisoglu E, et al. Qualiiyof life in chronic kidney disease: effects of treatment modality, dcpression, malnutrition and inflammation. Int J Clin Pratt.2007;61(4): 569-576.
  • 9O'Carroll RE, Smith K, Couston M, et al. A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res. 2000; 9(1): 121-124.
  • 10Burra P, De Bona M, Germani G, et al. The concept of quality of lifc in organ transplantation. Transplant Proc. 2007;39(7): 2285-2287.

共引文献32

同被引文献33

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部